These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7015718)

  • 1. [Current status of the prostacyclin story for clinical use].
    Sinzinger H; Silberbauer K
    Vasa; 1981; 10(1):70-3. PubMed ID: 7015718
    [No Abstract]   [Full Text] [Related]  

  • 2. Epoprostenol (prostacyclin) and severe arterial disease. A double-blind trial.
    Belch JJ; McKay A; McArdle B; Leiberman P; Pollock JG; Lowe GD; Forbes CD; Prentice CR
    Lancet; 1983 Feb; 1(8320):315-7. PubMed ID: 6130330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet responses observed during and after infusions of the prostacyclin analog ZK 36 374.
    Yardumian DA; Mackie IJ; Bull H; Machin SJ
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 13():359-62. PubMed ID: 2408446
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostacyclin in vascular pathology--therapeutic possibilities.
    Gryglewski RJ; Szczeklik A
    Ann Clin Res; 1984; 16(5-6):253-61. PubMed ID: 6398663
    [No Abstract]   [Full Text] [Related]  

  • 5. Prostacyclin: a prostaglandin with therapeutic potential.
    Vane JR
    Arch Farmacol Toxicol; 1982 Aug; 8(2):51-76. PubMed ID: 6818907
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of occlusive coronary artery thrombosis by prostacyclin infusion in the dog.
    Romson JL; Haack DW; Abrams GD; Lucchesi BR
    Circulation; 1981 Nov; 64(5):906-14. PubMed ID: 7026083
    [No Abstract]   [Full Text] [Related]  

  • 7. [Prostaglandins including prostacyclin in the treatment of peripheral arterial occlusive disorders].
    Alexander K
    Internist (Berl); 1989 Jul; 30(7):429-39. PubMed ID: 2670810
    [No Abstract]   [Full Text] [Related]  

  • 8. A randomized, placebo controlled trial of prostacyclin (PGI2) in peripheral arterial disease.
    Hossman V; Heinen A; Auel H; FitzGerald GA
    Thromb Res; 1981 May; 22(4):481-90. PubMed ID: 7027528
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical potential of prostacyclin.
    Vane JR
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():449-56. PubMed ID: 6221561
    [No Abstract]   [Full Text] [Related]  

  • 10. Pilot study of the effects of taprostene (CG 4203) in patients with advanced peripheral arterial disease.
    Darius H; Kopp H; Mulfinger A; Spielberger M; Todt M; Schuster CJ; Meyer J
    Prog Clin Biol Res; 1989; 301():417-21. PubMed ID: 2508112
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostacyclin in therapeutics.
    Lancet; 1981 Mar; 1(8221):643-4. PubMed ID: 6110866
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of chronic kidney transplant rejection with prostacyclin - reduction of platelet deposition in the transplant; prolongation of platelet survival and improvement of transplant function.
    Leithner C; Sinzinger H; Schwarz M
    Prostaglandins; 1981 Nov; 22(5):783-8. PubMed ID: 7036226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful therapy of advanced arteriosclerosis obliterans with prostacyclin.
    Szczeklik A; Nizankowski R; Skawinski S; Szczeklik J; Gluszko P; Gryglewski RJ
    Lancet; 1979 May; 1(8126):1111-4. PubMed ID: 86835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostacyclin infusion during extracorporeal circulation foe coronary bypass.
    Rådegran K; Arén C; Teger-Nilsson AC
    J Thorac Cardiovasc Surg; 1982 Feb; 83(2):205-11. PubMed ID: 7035754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostacyclin in Falciparum malaria.
    Weston MJ; Jackman N; Rudge C; Bowles J; Brady C; Bielawska C; O'Grady J
    Lancet; 1982 Sep; 2(8298):609. PubMed ID: 6125752
    [No Abstract]   [Full Text] [Related]  

  • 16. Action of prostacyclin (PGI2) and prostaglandin E2 (PGE2) on gastric secretion and mucosal blood flow in dogs.
    Konturek SJ
    Gastroenterology; 1980 Jul; 79(1):182-4. PubMed ID: 6991360
    [No Abstract]   [Full Text] [Related]  

  • 17. [Significance of prostaglandins in arterial occlusive diseases].
    Diehm C
    Internist (Berl); 1994 Aug; 35(8):764-70; discussion 771-2. PubMed ID: 7960555
    [No Abstract]   [Full Text] [Related]  

  • 18. Salvage of the severely ischaemic limb by intra-arterial prostacyclin (PGI2) infusion. A case report.
    Søreide O; Segadal L; Trippestad A; Engedal H
    Scand J Thorac Cardiovasc Surg; 1982; 16(1):71-3. PubMed ID: 7041251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostacyclin in peripheral arterial occlusive disease (PAOD): clinical and hemodynamic findings in patients with PAOD stage III and IV.
    Valentin A; Karnik R; Sehnal E; Slany J
    Prog Clin Biol Res; 1987; 242():457-62. PubMed ID: 3313420
    [No Abstract]   [Full Text] [Related]  

  • 20. Rationale and proposal for use of prostacyclin in thrombotic thrombocytopenic purpura therapy.
    Cocchetto DM; Cook L; Cato AE; Niedel JE
    Semin Thromb Hemost; 1981; 7(1):43-51. PubMed ID: 7015516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.